Publications
Search
APP Institute Oncology
05/08/2024
Sarah Smith, BD, CNMT, discusses findings from the phase 3 MARIPOSA study exploring post-progression and safety outcomes with first-line amivantamab plus lazertinib vs osimertinib for advanced NSCLC and offers guidance for best management practices.
Annals of Long-Term Care
05/08/2024
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/08/2024
Dr. W. Frank Peacock discussed a recently completed biomarker study that enrolled 840 individuals across 10 hospital locations in the United States. The study involved participants wearing RCE’s Infrasensor™ wearable device for three minutes during which blood samples were collected for biochemical analysis.
Oncology
Is There a Benefit to Sequential Antibody Drug Conjugates for Patients With Metastatic Breast Cancer
05/08/2024
At Great Debates and Updates in Women’s Oncology, Neil Iyengar, MD, discusses the lack of data to support the sequential use of antibody drug conjugates for patients with metastatic breast cancer.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/08/2024
Researchers at the University of Houston College of Pharmacy have discovered that when there's a higher amount of a protein called AKAP12 inside the heart, it speeds up the work of an enzyme called PDE8A and can accelerate cardiac dysfunction.
Oncology
05/08/2024
At the 2024 Great Debates and Updates in Women’s Oncology meeting, Bradley Monk, MD, FACOG, argues for the first-line use of immune checkpoint inhibitors plus chemotherapy and radiation therapy for patients with cervical cancer.
Oncology
05/08/2024
At the 2024 Great Debates and Updates in Women’s Oncology meeting, Bradley Monk, MD, FACOG, discussed PARP inhibitors and determining the optimal maintenance therapy for women with advanced epithelial ovarian cancer.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/08/2024
The researchers analyzed the potential of endothelial cells, which make up the protective inner layer of blood vessels, that express a protein called ABCG2 to make colonies, self-renew and form vessels. These cells could form new blood vessels and contributed to the repair of heart tissue blood vessels after a heart attack.
Cath Lab Digest
05/08/2024
In a new survey of over 3,000 Americans, KURU Footwear has compiled a new report—The 2024 State of Foot Pain Report.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular, Vascular Disease Management, IO Learning
05/08/2024
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
Cath Lab Digest
05/08/2024
Sahil A. Parikh, MD, Associate Professor of Medicine, Columbia University Irving Medical Center, and lead author of the study, said, “Evaluating care disparities in real clinical practices is key to addressing the existing barrier and improving patient outcomes.”
Gastroenterology
05/08/2024
Dr Brian Lacy brings Dr Douglas Drossman back to Gut Check for a follow-up podcast on disorders of gut-brain interaction, to review the use of neuromodulators in treatment.
Rheumatology & Arthritis, Autoimmune
05/08/2024
A scoping review of screening tools for spondyloarthritis found need for a better, patient-oriented screening tool.
ePlasty, Surgery
05/07/2024
This study compares the outcomes of treatment of scaphoid waist fractures with the use of distal radius and iliac crest bone grafts.
ePlasty, Surgery
05/07/2024
This case reports a multidisciplinary approach for excision and reconstruction of an intraosseous hemangioma of the zygomatic bone in a 54-year-old female.
ePlasty, Surgery
05/07/2024
This retrospective study compared pre- and postoperative nasal metrics and postoperative satisfaction in a cohort of transfeminine patients who underwent feminizing rhinoplasty.
Wound Care
05/07/2024
It was recently announced that Heberprot-P, a recombinant epidermal growth factor developed in Cuba, has been approved by the US FDA for the biotechnology company Discovery Therapeutics Caribe (DTC) to conduct a Phase III study of the drug in the US.
Wound Care
05/07/2024
Omeza presents final clinical data showing that Omeza plus offloading achieved a 94% area reduction (PAR) in DFUs at 12 weeks and 62% PAR at 4 weeks. Further studies to evaluate Omeza in VLUs are underway.
Wound Care
05/07/2024
A 40-patient study of vascular patients who underwent closure of groin incisions for Critical Limb Threatening Ischemia (CLTI) found that those who received Prevena NPWT had significantly reduced rates of infection, reoperation, and dehiscence compared to WOC dressing. Ann Plast Surg
Wound Care
05/07/2024
A multicenter RCT investigated the effectiveness of AQUACEL Ag+ Extra in the management of patients with VLUs. The study found that VLUs managed with AQUACEL Ag+ Extra were 31% more likely to heal completely at 12 weeks and 31% more likely to have a 40% reduction in wound area at 4 weeks.